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ABSTRACT
In the study, three aristololactams were isolated from Piper wallichii and determined simultaneously by a HPLC method using a C18
column with a gradient elution of methanol and water. The content ranges of the target compounds in twelve batches of Piper wallichii
were 0.100 - 0.110 mg/g dry weight (cepharanone B), 0.198 - 0.208 mg/g dry weight (aristolactam AII), and 0.047 - 0.059 mg/g dry weight
(aristololactam AIIIa), respectively. Their anti-proliferative effects in HK-2 cells were determined by MTT assay and cells membrane
damage were assessed by LDH release assay. Results indicated that the test compounds showed a time- and dose-dependent cytotoxicity
in HK-2 cells, and the values of IC50 were cepharanone B > aristolactam AII > aristololactam AIIIa.
Key words: Piper wallichii, Aristololactams, HPLC, Cytotoxicities

INTRODUCTION
Aristolochic acid nephropathy (AAN) is a progressive
tubulointerstitial renal disease, and is predominantly a result
of aristolochic acid (AA) intoxication(1). Some traditional
Chinese medicines containing AA have been observed to be
nephrotoxic(2). Owing to the severe nephrotoxicity of AA,
the US Food and Drug Administration declared a prohibition of using the products that contain AA, including Fructus
Aristolochiae, Caulis Aristolochiae Manshuriensis and other
eleven formulations(3,4).
Aristololactam (AL), as the important analog of AA,
exists in many medicinal plants. Meanwhile, it was reported
that AA could be converted to AL in the metabolism process
in vivo(5). Researchers found some ALs showed potential
cytotoxicity in the human proximal tubular epithelial (HK-2)
cell(6,7).
Piper wallichii is a perennial herb of the genus Piper,
which belongs to the family Piperaceae(8,9), and is widely
used for the treatment of dysaemia, pain, sexual disturbance
and beriberi disease. In the previous studies, three ALs
were isolated from the herb(10,11). Considering the potential
renal cytotoxicities of these ALs existing in P. wallichii, it is
necessary to study their renal cytotoxicities and establish a
* Author for correspondence. Tel: +86-27-83692311;
Fax: +86-27-83692762; E-mail: jinlan8152@163.com

quality control system for this herb. In this study, a proposed
strategy was developed to determine the contents of ALs in
P. wallichii by HPLC, and their renal cytotoxicities in vitro
were investigated in HK-2 cells.

MATERIALS AND METHODS
І. Plant Materials
Twelve batches of P. wallichii were collected from
Wufeng County, Hubei Province, China, and identified by the
Associate Chief Pharmacist Zuhai Zhou, Institute of Drug
Control of Wufeng County. A voucher specimen (PW0825)
was deposited in the herbarium of College of Pharmacy,
Tongji Medical Center, Huazhong University of Science and
Technology.
II. Reference Prepared from P. wallichii
The reference compounds were isolated from the dried
herb of P. wallichii in our laboratory(10,11), and were identified by UV, IR, ESI-MS, 1H-NMR and 13C-NMR(12-14).
Among them, cepharanone B, aristolactam AII, and aristololactam AIIIa were included. The purity of each compound
was determined to be higher than 98% by HPLC. The
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chemical structures of the reference compounds are shown
in Figure 1.
III. Pharmacological Studies in Vitro
(І) Materials
HK-2 cells were obtained from the Cell Culture Center
of Wuhan College (Wuhan, China). Dulbecco’s modified
Eagle’s medium/F12 (DMEM/F12) and fetal bovine serum
(FBS) were purchased from Ginuo (Hangzhou, China).
Dimethyl sulfoxide (DMSO) (99.9%), mercuric chloride
(HgCl2) and 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) were purchased from Sigma
(MO, USA). LDH kits were provided by Nanjing Jiancheng
Biology Engineering Institute (Nanjing, China). The reference compounds were first dissolved in DMSO, and then
diluted in cell culture medium. The final concentration of
DMSO in all preparations was 0.5% (v/v).
(II) Cell Culture
HK-2 cells were maintained in DMEM/F12 supplemented with 10% FBS at 37°C in an atmosphere containing
5% CO2.
(III) Cytotoxicity Assay
Cytotoxicity was determined using MTT assay as
described by Mosmann(15) with minor modifications. In
brief, HK-2 cells (100 µL) were seeded at 105 cells/mL in
96-well plates. After 24 h, the cells were exposed to 100 µL
of 0.5% DMSO (vehicle control), culture medium without
any test compound, 2.5 mg/L HgCl2, 2.5, 5, 10, 20, 40, 80 and
160 mg/mL of cepharanone B, aristolactam AII or aristololactam AIIIa dissolved in FBS free medium. Each condition
was tested in four replicates and three independent experiments were carried out. Following incubation for 24 h, 48 h
or 72 h, MTT was added and cells were incubated for additional 4 h. The absorbance was then measured at 570 nm on a
microplate reader (SLT, Crailsheim, Germany). Relative cell
viability (%) was calculated as (mean absorbance of sample/
mean absorbance of vehicle control) × 100. Median inhibition concentration (IC50) was defined as the drug concentration that resulted in 50% of cell viability inhibition.

(IV) Lactate Dehydrogenase (LDH) Assay
The integrity of cell membrane was examined by
measuring the release of LDH. The cells were treated the
same as described in section III(III). 0.5% of DMSO was
used as vehicle control. After 24 h of exposure, the release of
LDH was measured using the LDH assay kit (Nanjing, China)
according to the method described by Lorentz(16). Each
condition was tested in four replicates and three independent
experiments were carried out. The LDH release rate (%) was
calculated as LDH content in the medium / (LDH content in
the medium + LDH content in cell lysis solution) × 100.
IV. HPLC Analysis
(І) Equipment and Chromatographic Conditions
The HPLC system (Hitachi, Japan) was equipped with a
Model L-2130 pump, an on-line solvent vacuum degasser, an
auto sampler with 20 µL injection loop, and an L-2400 UV
detector. T2000P software was used to record chromatograms
and calculate peak areas. Chromatographic separations were
carried out on an Agilent TC-C18 column (250 mm × 4.6
mm, 5 μm). A binary gradient elution system consisting of
methanol (A) and water (B), and was used with the following
gradient program: 0 - 35 min, 43 - 68% A; 35 - 50 min,
68 - 100% A; The flow rate was set at 1.0 mL/min. The
column temperature was set at 25°C. The injection volume
was 20 µL. The detection wavelength was 287 nm.
(II) Standards Preparation and Calibration Curves
Cepharanone B (6.6 mg), aristolactam AII (5.3 mg), and
aristololactam AIIIa (3.75 mg) were dissolved in a 10 mL
volumetric flask with methanol to prepare the mixed standard stock solution. Working standards at the concentration
of the calibration range were prepared by stepwise dilution
with methanol. The quantitative analysis was performed by
the external standard method: the calibration curve for each
species was obtained after subjecting a series of standard
solutions to the same analytical procedure. The calibration
curve was obtained by peak area/corresponding concentration of the injected standard solutions, and the concentrations
of target compounds in the samples were calculated based on
the calibration curve.
(III) Sample Preparation
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Figure 1. Chemical structures of cepharanone B; aristolactam AII;
aristololactam AIIIa.

The herbs of P. wallichii were dried at room temperature
and crashed into powder (20 meshes). The resulting powder
was accurately weighed (about 1 g) and then was extracted
with 20 mL methanol in a reflux bath at 85°C for 30 min and
then cooled at room temperature. The extract was filtered
through a 0.45 μm polytetrafluoroethylene membrane filter
(Tianjin Jinteng Instrument Factory, Tianjin, China). The
herbal extract was transferred into a 20 mL volumetric flask,
and adjusted to volume with methanol.
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V. Statistical Analysis
In order to classify the target herbal plants, hierarchical
clustering analysis (HCA) was performed by using SPSS
software (SPSS for windows 11.0, SPSS, USA). In the study
on pharmacology, all values are expressed as means ± SD.
Differences were considered significant at p < 0.05.

І. In Vitro Pharmacological Studies
(І) Cytotoxicity of ALs in HK-2 Cells
The cytotoxicity of cepharanone B; aristolactam AII
and aristololactam AIIIa in HK-2 cells was determined by
MTT assay. The cell viability results for various concentrations of three ALs with 24, 48 and 72 h of incubation are
shown in Figure 2 and IC50 values are provided in Table 1.
HgCl2 (2.5 mg/L), a known nephrotoxic agent, exhibited
significant decrease (p < 0.05) in HK-2 cells viability, which
was similar to the previous study and verified the in vitro
testing system(17). As shown in Table 1, the values of IC50
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Table 1. The median inhibition concentration (IC50) of cepharanone
B, aristololactam AIIIa in HK-2 cells following incubation for 24, 48
and 72 h, respectively
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(ІІ) Cell Membrane Injury Caused by ALs
To investigate the effects of cepharanone B, aristolactam AII and aristololactam AIIIa on the membrane
integrity, the release of LDH was examined with 0.5%

RESULTS AND DISCUSSION

(A)

were cepharanone B > aristolactam AII > aristololactam
AIIIa, indicating Aristololactam AIIIa as the most and
Cepharanone B the least toxic in HK-2 cells. Furthermore,
the cytotoxicities exhibited in a time- and dose-dependent
manner.
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Figure 2. Concentration-dependent effect of cepharanone B (A),
aristolactam AII (B) and aristololactam AIIIa (C) on HK-2 cell
viability. The data represented mean ± SD. from three independent
experiments.
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DMSO as vehicle control. The result of the LDH release
was similar to that of the MTT assay. As shown in Figure
3, exposure of HK-2 cells to ALs for 24 h led to significant
increase of the LDH release (p < 0.05) in a concentrationdependent manner. Aristolactam AII and aristololactam
AIIIa showed higher LDH release rate than cepharanone B,
suggesting that aristolactam AII and aristololactam AIIIa
led to greater damage to cell membrane and manifested
stronger cytotoxicity than cepharanone B.
ІІ. Phytochemical Studies by HPLC

maxima of the reference compounds in UV spectra acquired
by UV-756 MC Spectrophotometer (Shanghai Precision &
Scientific Instrument Co., Shanghai, China), the monitoring
wavelength was set at 287 nm.
(ІІІ) Method Validation
The proposed method was validated in terms of linearity,
limits of detection (LODs), quantification (LOQs), precision,
repeatability and recovery test.
1. Linearity, Limits of Detection and Quantification
Six concentrations of the reference compounds solution

In order to obtain optimal extraction efficiency of
P. wallichii for HPLC analysis, three relative extraction
conditions were designed and evaluated, which involved
the following factors and corresponding levels: extraction
method (ultrasonication, reflux), extraction temperature
(75, 80 and 85°C) and extraction time (0.5, 1 and 2 h). By
comparing the sum numbers and areas of target peaks in
each chromatogram of different factors, the condition was
optimized as follows: 1.0 g powder of dried sample extracted
with 20 mL methanol in a reflux bath at 85°C for 1 h.
(ІІ) Optimization of HPLC Condition
In order to achieve good resolution of chromatography, the mobile phase, detection wavelength and profiles
of gradient elution were systematically investigated. The
results indicated that there was no obvious difference
between methanol-water and acetonitrile-water. Considering
the high-toxicity and price of acetonitrile, the binary mixture
of methanol-water was chosen. On the basis of the absorption
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Figure 3. The LDH release rate in HK-2 cells exposed to various
concentrations of cepharanone B, aristolactam AII and aristololactam
AIIIa, respectively, for 24 h. The data represented mean ± SD. from
three independent experiments. *p < 0.05, compared with the vehicle
control.

Table 2. Calibration curves, detection limits and quantification limits of the target compounds
Calibration curvea

Linear range (μg/mL)

R2 (n = 5)b

LOD (ng)c

LOQ (ng)d

Cepharanone B

y = 75186x - 23723

1.66 - 26.5

0.9997

0.41

1.36

Aristolactam AII

y = 70599x + 17091

1.33 - 21.2

0.9996

0.25

1.74

Aristololactam AIIIa

y = 55145x - 5850

0.94 - 15.0

0.9999

0.13

0.42

Compound

a

y, peak area; x, the concentration of each reference compound (μg/mL).
b
R, correlation coefficient of regression equations.
c
Limit of detection (S/N = 3).
d
Limit of quantification (S/N = 10).

Table 3. The intra- and inter-day variability and repeatability of the target compounds in Piper wallichii
Intra-day (n = 6)
Compound

Inter-day (n = 6)

Repeatability (n = 6)

Content
(mg/g dry weight)

RSD (%)

Content
(mg/g dry weight)

RSD (%)

Content
(mg/g dry weight)

RSD (%)

Cepharanone B

0.105

1.8

0.106

2.3

0.104

0.9

Aristolactam AII

0.201

1.4

0.201

2.5

0.203

1.8

Aristololactam AIIIa

0.052

1.7

0.055

2.8

0.050

1.3
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Table 4. Recovery of each compound determined by standard addition method (n = 3)a
Compound

Original (mg)

Spiked (mg)

Found (mg)

Recovery (%)

RSD (%)

Cepharanone B

0.105

0.200

0.306

100.3

1.8

Aristolactam AII

0.201

0.200

0.403

101.1

2.5

Aristololactam AIIIa

0.052

0.100

0.151

99.1

2.6

a

The data was present as average of three determinations. Recovery (%) = 100 × (amount found-original amount)/amount spiked.

Table 5. Contents (mg/g dry weight) of the target compounds in
different samples (n = 3)
Aristolactam AII

Aristololactam
AIIIa

080423

0.103

0.198

0.049

080428

0.105

0.202

0.054

080503

0.103

0.200

0.050

080510

0.108

0.202

0.051

080518

0.104

0.201

0.050

080527

0.105

0.205

0.053

080530

0.102

0.200

0.049

080608

0.110

0.208

0.059

080615

0.106

0.204

0.052

080620

0.100

0.198

0.047

080628

0.105

0.206

0.053

080706

0.107

0.207

0.058

40
30

mv
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1

20

2
3

10
0

0

10

20
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Time (min)
200

(B)

150

mv

Sample

(A)

50
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50

2
3
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0

10
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Time (min)

were injected in triplicate, and the calibration curves were
obtained. LOD and LOQ under the chromatographic conditions were determined at signal-to-noise ratios (S/N) of 3
and 10, respectively. As shown in Table 2, good linearity
(coefficient of determination R2 > 0.999) was obtained in
the studied ranges for the target compounds.
2. Precision Test
Intra- and inter-day variations were utilized to
determine the method precision. The intra- and inter-day
variations were determined by analyzing six replicates on
one day and on three consecutive days. Variations were
expressed as relative standard deviations (RSD). As shown
in Table 3, the RSD values of the overall intra- and inter-day
variations were less than 2.8%.
3. Repeatability Test
The repeatability was confirmed by analyzing six
different working solutions prepared from the same sample.
As shown in Table 3, the RSD values of the repeatability were
less than 1.8% for all the target compounds.
4. Recovery Test
In order to validate the accuracy of the method, a known
amount (low, medium and high levels) of the three standard
compounds were spiked into about 1.0 g of the herb of P.

Figure 4. (A) Chromatogram of standard mixture compounds; (B)
Chromatogram of Piper wallichii extract; (1) cepharanone B; (2) aristolactam AII; (3) aristololactam AIIIa.

wallichii, and then subjected to the extraction procedure as
described in materials and methods section IV(ІІІ). The
extracts were analyzed by HPLC and the results are shown
in Table 4. The RSD were less than 2.6% and the recoveries
of all compounds varied from 99.1 to 101.1%. The results
showed good reliability and accuracy.
(IV) Sample Analysis
All samples were processed by the optimized extraction
method and analyzed under the optimized HPLC conditions.
Each sample was analyzed in triplicate to determine the
mean content and the results are tabulated in Table 5. The
chromatograms of the reference compounds and sample are
shown in Figure 4. The content ranges were 0.100 - 0.110 mg/g
dry weight, 0.198 - 0.208 mg/g dry weight and 0.047 - 0.059
mg/g dry weight for cepharanone B, aristolactam AII and
aristololactam AIIIa, respectively. In addition, via the multivariable analysis in SPSS software, the result showed that the
contents of 12 batches of samples were different (p < 0.05).

354
Journal of Food and Drug Analysis, Vol. 19, No. 3, 2011

Figure 5. The clustering analyses of chromatograms of 12 batches
of Piper wallichii samples. (1) 080423; (2) 080428; (3) 080503; (4)
080510; (5) 080518; (6) 080527; (7) 080530; (8) 080608; (9) 080615;
(10) 080620; (11) 080628; (12) 080716.

(V) Hierarchical Clustering Analysis
In order to classify the different batches of P. wallichii,
the clustering analysis was operated in SPSS software, and
the results are shown in Figure 5. The peak areas of three
target compounds were selected as the clustering variable,
average linkage between groups was applied and Euclidean
distance was selected as measurement. The result showed
that 12 batches of the samples could be classified into two
categories containing 2 and 10 samples. Accordingly, 10
batches of P. wallichii could be classified into 2 categories
containing 3 and 7 samples. We supposed that the contents
of major constituents in these batches were significantly
different and the picking time was a major factor.

CONCLUSIONS
In our study, the potential renal cytotoxicities in vitro
and the contents of the ALs in P. wallichii were analyzed.
The overall results provided further evidence to establish
the quality and safety control method, but the nephrotoxicity
of ALs have not been confirmed, which need more in-depth
studies.
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